Article

Non-penetrating canaloplasty may offer safe alternative to trabeculectomy in POAG

San Francisco- Non-penetrating canaloplasty may provide an effective and safe alternative to standard trabeculectomy in patients with primary open-angle glaucoma (POAG), according to Diamond Y. Tam, MD, University of Toronto.

San Francisco- Non-penetrating canaloplasty may provide an effective and safe alternative to standard trabeculectomy in patients with primary open-angle glaucoma (POAG), according to Diamond Y. Tam, MD, University of Toronto.

"[Although] trabeculectomy long has been considered the gold standard for surgical IOP control, it has an extensive short- and long-term risk profile that we’re all familiar with," Dr. Tam said. "So new procedures have been sought that might improve upon that risk profile while maintaining fairly good IOP control."

Dr. Tam and colleagues conducted a retrospective chart review of 25 patients with POAG who underwent either canaloplasty or trabeculectomy. This consecutive case series study was non-randomized. Patients who underwent trabeculectomy received adjunctive intraoperative mitomycin C. Visual acuity, IOP, and number of glaucoma medications were recorded preoperatively and at 6 months and 1 year postoperatively.

Both procedures were effective at reducing IOP and the number of topical glaucoma medications being taken by patients. In patients who underwent trabeculectomy, IOP was reduced from a mean of 25.7 to 10.5 mm Hg (p p

"Non-penetrating canalopasty was not significantly different from trabeculectomy at 1-year follow-up in terms of IOP or medication usage," Dr. Tam said. "Complications and adjunctive procedures were similar, and the two cases of hypotony were both in the trabeculectomy group."

In the search for safer alternative surgical therapies to trabeculectomy, the lack of any cases of hypotony in the canaloplasty group is significant, he concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.